|
HY-P72084-10ug
|
MedChemexpress LLC
|
Apolipoprotein E/APOE, Rabbit (His-B2M, Myc)
|
|
|
|
|
HY-P72084-5ug
|
MedChemexpress LLC
|
Apolipoprotein E/APOE, Rabbit (His-B2M, Myc)
|
|
|
|
|
HY-P72084-50ug
|
MedChemexpress LLC
|
Apolipoprotein E/APOE, Rabbit (His-B2M, Myc)
|
|
|
|
|
HY-P72766-10ug
|
MedChemexpress LLC
|
B7-2/CD86, Rabbit (HEK293, His)
|
|
|
|
|
HY-P72766-50ug
|
MedChemexpress LLC
|
B7-2/CD86, Rabbit (HEK293, His)
|
|
|
|
|
HY-P99470-1mg
|
MedChemexpress LLC
|
Benufutamab [CAS 2109730-69-8]
|
|
Cancer-programmed cell death
|
|
|
HY-P99470-10mg
|
MedChemexpress LLC
|
Benufutamab [CAS 2109730-69-8]
|
|
Cancer-programmed cell death
|
|
|
HY-P99470-5mg
|
MedChemexpress LLC
|
Benufutamab [CAS 2109730-69-8]
|
|
Cancer-programmed cell death
|
|
|
HY-P72122-10ug
|
MedChemexpress LLC
|
CD40L/CD154/TRAP, Rabbit (His)
|
|
|
|
|
HY-P72122-5ug
|
MedChemexpress LLC
|
CD40L/CD154/TRAP, Rabbit (His)
|
|
|
|
|
HY-P72122-50ug
|
MedChemexpress LLC
|
CD40L/CD154/TRAP, Rabbit (His)
|
|
|
|
|
HY-106662-10mg
|
MedChemexpress LLC
|
Chloroquinoxaline sulfonamide [CAS 97919-22-7]
|
|
Cancer-programmed cell death
|
|
|
HY-106662-100mg
|
MedChemexpress LLC
|
Chloroquinoxaline sulfonamide [CAS 97919-22-7]
|
|
Cancer-programmed cell death
|
|
|
HY-106662-25mg
|
MedChemexpress LLC
|
Chloroquinoxaline sulfonamide [CAS 97919-22-7]
|
|
Cancer-programmed cell death
|
|
|
HY-106662-5mg
|
MedChemexpress LLC
|
Chloroquinoxaline sulfonamide [CAS 97919-22-7]
|
|
Cancer-programmed cell death
|
|
|
HY-106662-50mg
|
MedChemexpress LLC
|
Chloroquinoxaline sulfonamide [CAS 97919-22-7]
|
|
Cancer-programmed cell death
|
|
|
HY-106662-1mL
|
MedChemexpress LLC
|
Chloroquinoxaline sulfonamide [CAS 97919-22-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-B1287-10mg
|
MedChemexpress LLC
|
Citalopram (hydrobromide) [CAS 59729-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-B1287-100mg
|
MedChemexpress LLC
|
Citalopram (hydrobromide) [CAS 59729-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-B1287-5mg
|
MedChemexpress LLC
|
Citalopram (hydrobromide) [CAS 59729-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-B1287-50mg
|
MedChemexpress LLC
|
Citalopram (hydrobromide) [CAS 59729-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-B1287-1mL
|
MedChemexpress LLC
|
Citalopram (hydrobromide) [CAS 59729-32-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-153235-500ug
|
MedChemexpress LLC
|
COVID-19 Spike Protein mRNA-LNP
|
|
|
|
|
HY-134669-10mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
|
HY-134669-100mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
